D. P. Baldani

发表

The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment

M. Kasum, D. P. Baldani, L. Škrgatić, 2018, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Association of PPARG Pro12Ala polymorphism with insulin sensitivity and body mass index in patients with polycystic ovary syndrome.

K. Geršak, J. Cerne, P. Ferk, 2014, Biomedical reports.

Does unilateral laparoscopic diathermy adjusted to ovarian volume increase the chances of ovulation in women with polycystic ovary syndrome?

I. Palada, A. Jerončić, M. Tandara, 2013, Human reproduction.

Association of PPARG Pro 12 Ala polymorphism with insulin sensitivity and body mass index in patients with polycystic ovary syndrome

K. Geršak, J. Cerne, P. Ferk, 2014 .

Influence of human embryo cultivation in a classic CO2 incubator with 20% oxygen versus benchtop incubator with 5% oxygen on live births: the randomized prospective trial

M. Milošević, Nina Gelo, P. Stanić, 2019, Zygote.

Association between serum levels and pentanucleotide polymorphism in the sex hormone binding globulin gene and cardiovascular risk factors in females with polycystic ovary syndrome.

K. Geršak, J. Cerne, Saša Kralik Oguić, 2015, Molecular medicine reports.

Altered leptin, adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic ovary syndrome abnormality

M. Kasum, M. Herman, D. P. Baldani, 2019, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

K. Geršak, J. Cerne, M. Ćorić, 2013 .

Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women.

K. Geršak, J. Cerne, M. Ćorić, 2013, Collegium antropologicum.

Ikaros Family Transcription Factors Expression in Rat Thymus: Detection and Impaired Development

M. Antica, S. Novak, T. Niksic, 2012, International journal of immunopathology and pharmacology.

Sex Hormone Binding Globulin (SHBG) as a Marker of Clinical Disorders.

Karlo Toljan, D. P. Baldani, Marina Sprem Goldstajn, 2016, Collegium antropologicum.

Metabolic implications of menstrual cycle length in non-hyperandrogenic women with polycystic ovarian morphology

L. Duvnjak, N. Stojanovic, M. Alebić, 2016, Endocrine.

Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women

D. P. Baldani, L. Škrgatić, Roya Ougouag, 2015, International journal of endocrinology.

CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels

K. Geršak, J. Cerne, P. Ferk, 2012, The Journal of Steroid Biochemistry and Molecular Biology.

Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population.

T. Čanić, D. P. Baldani, L. Škrgatić, 2013, Collegium Antropologicum.

Local estrogen treatment in patients with urogenital symptoms

I. Banović, D. P. Baldani, V. Šimunić, 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.